TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma

被引：0

作者：

Healy, Shannon ^{[1
]}

Ennishi, Daisuke ^{[1
]}

Bashashati, Ali ^{[1
]}

Saberi, Saeed ^{[1
]}

Hother, Christoffer ^{[1
]}

Mottok, Anja ^{[1
]}

Chan, Fong Chun ^{[2
]}

Chong, Lauren ^{[1
]}

Kridel, Robert ^{[3
]}

Boyle, Merrill ^{[1
]}

Meissner, Barbara ^{[1
]}

Aoki, Tomohiro ^{[1
]}

Takata, Katsuyoshi ^{[1
]}

Woolcock, Bruce W. ^{[1
]}

Vigano, Elena ^{[1
]}

Abraham, Libin ^{[2
]}

Gold, Michael ^{[2
]}

Telenius, Adele ^{[1
]}

Farinha, Pedro ^{[1
]}

Slack, Graham ^{[1
]}

Ben-Neriah, Susana ^{[1
]}

Lai, Daniel ^{[1
]}

Zhang, Allen W. ^{[1
]}

Salehi, Sohrab ^{[1
]}

Shulha, Hennady P. ^{[1
]}

Chiu, Derek S. ^{[2
]}

Mostafavi, Sara ^{[2
]}

Gerrie, Alina S. ^{[1
]}

Villa, Diego ^{[1
]}

Sehn, Laurie H. ^{[1
]}

Savage, Kerry J. J. ^{[1
]}

Mungall, Andrew J. J. ^{[1
]}

Weng, Andrew P. ^{[1
]}

Bally, Marcel ^{[1
]}

Morin, Ryan D. ^{[4
]}

Freue, Gabriela V. Cohen ^{[2
]}

Connors, Joseph M. ^{[1
]}

Marra, Marco A. ^{[1
]}

Shah, Sohrab P. ^{[1
]}

Gascoyne, Randy D. ^{[1
]}

Scott, David W. ^{[1
]}

Steidl, Christian ^{[1
]}

Steidl, Ulrich ^{[5
]}

机构：

[1] BC Canc Agcy, Vancouver, BC, Canada

[2] Univ British Columbia, Vancouver, BC, Canada

[3] Univ Hlth Network, Toronto, ON, Canada

[4] Simon Fraser Univ, Vancouver, BC, Canada

[5] Albert Einstein Coll Med, Bronx, NY 10467 USA

来源：

CANCER RESEARCH | 2019年 / 79卷 / 13期

关键词：

D O I：

10.1158/1538-7445.SABCS18-3480

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3480

引用

页数：10

共 39 条

[31] Inactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells
O'Hayre, M.
Inoue, A.
Kufareva, I.
Wang, Z.
Mikelis, C. M.
Drummond, R. A.
Avino, S.
Finkel, K.
Kalim, K. W.
DiPasquale, G.
Guo, F.
Aoki, J.
Zheng, Y.
Lionakis, M. S.
Molinolo, A. A.
Gutkind, J. S.
ONCOGENE, 2016, 35 (29) : 3771 - 3780
[32] Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
Y Xia
Z Y Xu-Monette
A Tzankov
X Li
G C Manyam
V Murty
G Bhagat
S Zhang
L Pasqualucci
C Visco
K Dybkaer
A Chiu
A Orazi
Y Zu
K L Richards
E D Hsi
W W L Choi
J H van Krieken
J Huh
M Ponzoni
A J M Ferreri
M B Møller
B M Parsons
J N Winter
M A Piris
J Westin
N Fowler
R N Miranda
C Y Ok
Y Li
J Li
L J Medeiros
K H Young
Leukemia, 2017, 31 : 625 - 636
[33] Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma
Xia, Y.
Xu-Monette, Z. Y.
Tzankov, A.
Li, X.
Manyam, G. C.
Murty, V.
Bhagat, G.
Zhang, S.
Pasqualucci, L.
Visco, C.
Dybkaer, K.
Chiu, A.
Orazi, A.
Zu, Y.
Richards, K. L.
Hsi, E. D.
Choi, W. W. L.
van Krieken, J. H.
Huh, J.
Ponzoni, M.
Ferreri, A. J. M.
Moller, M. B.
Parsons, B. M.
Winter, J. N.
Piris, M. A.
Westin, J.
Fowler, N.
Miranda, R. N.
Ok, C. Y.
Li, Y.
Li, J.
Medeiros, L. J.
Young, K. H.
LEUKEMIA, 2017, 31 (03) : 625 - 636
[34] Loss-of-Function of MYO5B is the Main Cause of Microvillus Inclusion Disease: 15 Novel Mutations and a CaCo-2 RNAi Cell Model
Ruemmele, Frank M.
Mueller, Thomas
Schiefermeier, Natalia
Ebner, Hannes L.
Lechner, Silvia
Pfaller, Kristian
Thoeni, Cornelia E.
Goulet, Olivier
Lacaille, Florence
Schmitz, Jacques
Colomb, Virginie
Sauvat, Frederique
Revillon, Yann
Canioni, Danielle
Brousse, Nicole
de Saint-Basile, Genevieve
Lefebvre, Juliette
Heinz-Erian, Peter
Enninger, Axel
Utermann, Gerd
Hess, Michael W.
Janecke, Andreas R.
Huber, Lukas A.
HUMAN MUTATION, 2010, 31 (05) : 544 - 551
[35] Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma
Jordanova, ES
Philippo, K
Giphart, MJ
Schuuring, E
Kluin, PM
IMMUNOGENETICS, 2003, 55 (04) : 203 - 209
[36] Mutations in the HLA class II genes leading to loss of expression of HLA-DR and HLA-DQ in diffuse large B-cell lymphoma
Ekaterina S. Jordanova
Katja Philippo
Marius J. Giphart
Ed Schuuring
Philip M. Kluin
Immunogenetics, 2003, 55 : 203 - 209
[37] TP53 mutations and RNA-binding protein MUSASHI-2 drive resistance to PRMT5-targeted therapy in B-cell lymphoma
Erazo, Tatiana
Evans, Chiara M.
Zakheim, Daniel
Chu, Karen L.
Refermat, Alice Yunsi
Asgari, Zahra
Yang, Xuejing
Ferreira, Mariana Da Silva
Mehta, Sanjoy
Russo, Marco Vincenzo
Knezevic, Andrea
Zhang, Xi-Ping
Chen, Zhengming
Fennell, Myles
Garippa, Ralph
Seshan, Venkatraman
de Stanchina, Elisa
Barbash, Olena
Batlevi, Connie Lee
Leslie, Christina S.
Melnick, Ari M.
Younes, Anas
Kharas, Michael G.
NATURE COMMUNICATIONS, 2022, 13 (01)
[38] Impact of Loss-of-Function and Dominant-Negative IKZF1 Deletions on Outcome in BCR-ABL1 Negative Pediatric B-Cell Acute Lymphoblastic Leukemia
Gupta, S.
Bakhshi, S.
Kamal, V.
PEDIATRIC BLOOD & CANCER, 2018, 65 : S119 - S119
[39] Cytogenetic Analysis of CpG-Oligonucleotide DSP30 plus Interleukin-2-Stimulated Canine B-Cell Lymphoma Cells Reveals the Loss of One X Chromosome as the Sole Abnormality
Reimann-Berg, N.
Escobar, H. Murua
Kiefer, Y.
Mischke, R.
Willenbrock, S.
Eberle, N.
Nolte, I.
Bullerdiek, J.
CYTOGENETIC AND GENOME RESEARCH, 2011, 135 (01) : 79 - 82

← 1 2 3 4 →